Fairbanks Pharmaceuticals

Curing diabetes through beta cell repair and regeneration

Skip to content
  • Home
  • About Us
  • Company News
  • Contact Us

Fairbanks M2D2 Challenge Profile

March 28, 2018Company NewsMark Schneyer

Tonight is the Challenge Pitch-off for the  M2D2 $200K Challenge, and Fairbanks will be there competing as one of 20 finalists.

Check out the interview with CEO Alan Schneyer published on the M2D2 site today!

Post navigation

← Fairbanks Presents at Endocrine Society Annual Meeting The Science Behind the Fairbanks Therapeutic Strategy →
Proudly powered by WordPress